该研究有望推动钙钛矿光伏技术在建筑一体化、可穿戴电子、新能源汽车等领域的商业化进程，为清洁 能源的未来发展注入新的科技动力。 为解决这一核心难题，研究团队独辟蹊径，开发出一种名为"晶体-溶剂化物预晶种"（CSV）的通用性 调控方法。该方法的核心在于，预先在基底上沉积一层特殊设计的低维卤化物溶剂化物晶体作为"晶 种"预先铺设于基底上。这一策略就像为钙钛矿薄膜的生长提前搭建了"引导支架"。通过这一协同机 制，研究人员成功在钙钛矿薄膜底部构筑了致密、平整、结晶取向更佳的高质量活性层，从根本上消除 了常见的埋底界面孔洞和深晶界等缺陷。 为了验证该策略的产业化潜力，团队进一步将其与适合大规模生产的"狭缝涂布"工艺相结合，成功制备 出入光面积达49.91cm2的钙钛矿太阳能微型组件，并获得了23.15%的认证效率，其从实验室小电池到 较大面积组件的效率损失率极低（小于3%），展现了卓越的工艺放大能力和均匀性控制水平。 这项研究为攻克反式钙钛矿太阳能电池的界面瓶颈提供了一个高效、通用的解决方案，其提出的"晶体- 溶剂化物预晶种"概念更是一个强大的材料平台，可通过改变组分衍生出多种功能化"晶种"，为钙钛矿 乃至其他新型软物质 ...

报告期内，影响公司经营业绩的主要原因系营业收入减少，同时，公司持续推进钙钛矿光伏组件产线项 目、首发募投项目、新型光伏建设项目及电网侧储能项目建设，前述相关资产于2025年度达到预定可使 用状态，折旧费用相应同比增加。当前，公司聚焦核心战略，加速开展各项经营业务，全力保障后续经 营计划的顺利推进。 格隆汇2月27日丨杭州柯林(688611.SH)公布2025年度业绩快报，报告期内，公司实现营业总收入2.07亿 元，同比减少61.83%；实现归属于母公司所有者的净利润-316.44万元，同比减少104.33%；实现归属于 母公司所有者的扣除非经常性损益的净利润-713.78万元，同比减少110.14%。 ...

报告期内，影响公司经营业绩的主要原因系营业收入减少，同时，公司持续推进钙钛矿光伏组件产线项 目、首发募投项目、新型光伏建设项目及电网侧储能项目建设，前述相关资产于2025年度达到预定可使 用状态，折旧费用相应同比增加。当前，公司聚焦核心战略，加速开展各项经营业务，全力保障后续经 营计划的顺利推进。 格隆汇2月27日丨杭州柯林(688611.SH)公布2025年度业绩快报，报告期内，公司实现营业总收入2.07亿 元，同比减少61.83%；实现归属于母公司所有者的净利润-316.44万元，同比减少104.33%；实现归属于 母公司所有者的扣除非经常性损益的净利润-713.78万元，同比减少110.14%。 ...

Core Insights - Innovation is the core driving force for development and a key to overcoming industrial bottlenecks [1] - The integration of innovation chains and industrial chains is crucial for the transformation of industrial clusters [1] Group 1: Longan Town's Mobile Industry - Longan Town has risen due to its mobile industry, which serves as the core engine for local development [3] - Each technological breakthrough and innovation in this sector creates tangible economic value and has the potential to reshape the industry landscape [3] Group 2: Product Innovation and Market Impact - A new mobile telephoto lens developed by He Jianwei's team weighs only 207 grams and incorporates 10 patented technologies, achieving performance comparable to professional long-focus lenses [5][6] - The lens has seen significant market success, with production increasing from 100 units per day at launch to over 20,000 units sold, indicating a strong "multiplicative effect" of innovation in Longan Town [10] Group 3: Government Support for R&D - Longan Town provides substantial support for R&D, including tax incentives and over 80 million yuan in annual innovation rewards, which serve as "invisible funds" for companies [8] - This financial backing has enabled companies like Yutong Optics to overcome technical challenges and achieve breakthroughs [8] Group 4: Historical Context of Innovation - Yutong Optics has a history of leveraging innovation to penetrate markets, having successfully entered the security lens sector in 2013 [12] - The company’s innovative products now contribute over 60% of its sales, with an annual growth rate of around 15% [14] Group 5: Economic Performance of Longan Town - Longan Town generates 13 billion yuan of GDP per square kilometer, with 11% of its GDP reinvested into R&D, showcasing its commitment to transforming manufacturing into intelligent manufacturing [16] Group 6: Innovations in Photovoltaic Industry - Yushan Town in Kunshan is a core hub for perovskite photovoltaic materials, which offer high light-to-electricity conversion efficiency, enhancing market competitiveness [17] - The company received investments from Kunshan High-tech Group, facilitating the transition from project incubation to industrialization [19] Group 7: Production Capacity Expansion - The first large-size photovoltaic module from GCL-Poly Energy was launched in November 2022, marking a significant breakthrough in new-generation photovoltaic products [21] - The production capacity was upgraded from 100 megawatts to 500 megawatts, entering a new phase of large-scale production [21] Group 8: Overall Innovation Momentum - Continuous breakthroughs in technology and the establishment of production lines are driving innovation momentum in the billion-yuan towns, setting a benchmark for high-quality economic development [22]

Group 1 - The current A-share market is likely to enter a favorable upward cycle, with the Shanghai Composite Index returning to around 4000 points, indicating a potential "timing, location, and human factors" opportunity for growth in the next 1-2 months [1] - The "spring market" period starting in February has historically shown high probabilities of upward movement, with small-cap indices having a 100% chance of rising between the Spring Festival and the Two Sessions, and an 87.5% chance of rising in February [1][2] - The annual report forecasts suggest that negative disturbances in the fundamentals are coming to an end, providing a more stable environment for investment [2] Group 2 - In a bullish market trend, every time the All A Index falls below the 20-day moving average, it often presents a good opportunity for accumulation [3] - The correlation between the "spring market" gains and the growth rate of the first quarter reports is strengthening, with key investment themes including the Byte industry chain and space photovoltaics [3][4] Group 3 - The perovskite solar industry is transitioning from megawatt-level research to gigawatt-level production, with leading companies like JinkoSolar and GCL-Poly Energy ramping up capacity [7] - Recent data shows that the laboratory efficiency of single-junction perovskite cells has reached 27.3%, and perovskite-silicon tandem cells have surpassed 35.0%, significantly exceeding the efficiency limits of crystalline silicon cells [7] - The global perovskite production capacity is expected to exceed 5GW by 2027 and potentially surpass 30GW by 2030, with the investment cost for a single GW production line decreasing from 1.5 billion yuan to around 1 billion yuan [7]

Core Viewpoint - China Nuclear Power's stock price has underperformed significantly compared to the A-share market, raising concerns among investors about the company's future valuation and operational performance [1][2]. Group 1: Stock Performance - Since the "9.24 market" in 2024, China Nuclear Power's stock has declined by 13.71%, lagging behind the Shanghai Composite Index by 61.71 percentage points [1]. - The stock price has fallen below the company's average repurchase price and is approaching the subscription price set by the National Social Security Fund [1][4]. - As of January 31, 2026, the company repurchased 44.90 million shares at an average price of 9.02 CNY per share, while the closing price on February 3, 2026, was 8.56 CNY [3]. Group 2: Financial Performance - In the first three quarters of 2025, the company reported revenue of 61.64 billion CNY, an increase of 8.16% year-on-year, but net profit fell by 10.42% to 8.00 billion CNY [4]. - The decline in net profit has been attributed to various factors, including decreased market electricity prices and increased tax burdens [6]. - Long-term growth potential remains, with a target of 259.2 billion kWh of electricity generation in 2026, a 6.04% increase from 2025 [6]. Group 3: Strategic Developments - The company is focusing on "strategic emerging industries," including high-tech investments and the development of new energy sources [10]. - A new subsidiary has been established to focus on perovskite photovoltaic components, with a fully automated production line already in place [10]. - The company has also developed a medical isotope production base, reducing reliance on imports and aiming for further innovation in this area [10]. Group 4: Market Outlook - Analysts suggest that while the nuclear power segment remains stable, the new energy business is under pressure due to declining electricity prices [7][8]. - The introduction of strategic investors may dilute earnings per share in the short term, and fluctuations in nuclear fuel costs could impact overall performance [9]. - The upcoming annual report in April 2026 will be critical for assessing the company's profitability amid market reforms [10].

证券日报网讯2月2日，中国核电（601985）在互动平台回答投资者提问时表示，公司敏捷端业务名称已 调整为战略新兴产业，目前正有序推动相关产业布局。公司控股设立的中核光电科技(上海)有限公司专 注于钙钛矿光伏组件的研发和制造，目前已建成刚性1600×1200mm全自动量产线，是行业内首条全国 产化产线，产品技术指标处于行业领先水平；公司已在秦山核电建成同位素生产基地，目前已实现 碳-14、钇-90、镥-177、锶-90等医用同位素商业化生产，打破源头进口依赖，为健康中国注入强劲动 力，公司未来将继续进行新型堆照同位素的开发，继续建设开发第二套同位素在线辐照生产装置。 ...

Core Viewpoint - The company is actively developing its strategic emerging industries, previously referred to as the agile end business, and has made significant advancements in various projects [1] Group 1: Business Development - The company has rebranded its agile end business to strategic emerging industries and is systematically promoting its related industrial layout [1] - The company has established a wholly-owned subsidiary, China Nuclear Power Technology (Shanghai) Co., Ltd., focusing on the research and manufacturing of perovskite photovoltaic components [1] - The company has built the first fully automated production line in the industry for rigid 1600×1200mm² components, which is the first domestically produced line in the country and has leading technical indicators in the industry [1] Group 2: Isotope Production - The company has established a medical isotope production base at Qinshan Nuclear Power, achieving commercial production of isotopes such as Carbon-14, Yttrium-90, Lutetium-177, and Strontium-90 [1] - This initiative has broken the dependency on imported sources, contributing significantly to the health sector in China [1] - The company plans to continue the development of new type pile irradiation isotopes and is working on the construction of a second online irradiation production facility for isotopes [1]

Group 1 - The company forecasts a net profit attributable to shareholders for 2025 to be between -3.06 million and -4.59 million RMB, representing a decrease of 76.09 million to 77.63 million RMB compared to the previous year, a year-on-year decline of 104.19% to 106.28% [1][2] - The expected net profit attributable to shareholders after deducting non-recurring gains and losses for 2025 is projected to be between -6.50 million and -9.75 million RMB, a decrease of 76.89 million to 80.14 million RMB compared to the previous year, reflecting a year-on-year decline of 109.23% to 113.85% [1][2] Group 2 - The company reported a net profit attributable to shareholders of 73.04 million RMB for 2024, with a net profit after deducting non-recurring gains and losses of 70.39 million RMB [2] - The primary reasons for the decline in net profit for 2025 include a year-on-year decrease in operating income and increased depreciation costs due to the commencement of several projects, including perovskite photovoltaic module production lines and energy storage projects [4]

Core Viewpoint - The company, Hangzhou Kolin (688611.SH), expects a significant decline in net profit for the year 2025, projecting a loss between RMB -3.06 million and -4.59 million, which represents a year-on-year decrease of approximately 104.19% to 106.28% compared to the previous year [1] Financial Performance - The projected net profit attributable to the parent company for 2025 is expected to decrease by RMB 76.1 million to 77.6 million compared to the previous year [1] - The expected net profit after deducting non-recurring gains and losses for 2025 is projected to be between RMB -6.5 million and -9.75 million, reflecting a decline of RMB 76.9 million to 80.1 million year-on-year [1] - The year-on-year decline in both net profit figures is primarily attributed to a decrease in operating revenue [1] Project Developments - The company is undertaking several projects, including the perovskite photovoltaic module production line, initial public offering fundraising projects, new photovoltaic construction projects, and grid-side energy storage projects [1] - These projects are expected to reach their intended usable state in 2025, leading to an increase in corresponding depreciation expenses [1]